The combination of reduced motility and fast loss of fat mass explains why gallbladder disease appears more often after starting these drugs
The data extraction was independently performed by two authors (DK and NA)
This eye-magination is envisioning alternative situations, by projecting innovative ideas into the future, while testing those together with participating actors, and sending the fruits of this confrontation back into potential futures
5.00 kg, P = 0.087)
Biodegradable Ultra-Thin Strut Supraflex Cruz Stent is Noninferior to Xience in TUXEDO-II Study Oct 28, 2025 by Natalie Morrison, CRTonline.org A biodegradablepolymer sirolimuseluting stent (BP-SES) with an ultra-thin strut, known Supraflex Cruz, was noninferior for target lesion failure (TLF) compared to the widely-used permanent everolimus-eluting stent (EES) Xience in diabetic patients with multi-vessel disease (MVD) at 1 year, Indias TUXEDO-2 randomized trial found
IV therapy involves delivering a precisely formulated blend of fluids, vitamins, and minerals directly into your vein through a small catheter